Peptostreptococcus anaerobius: Pathogenicity, identification, and antimicrobial susceptibility. Review of monobacterial infections and addition of a case of urinary tract infection directly identified from a urine sample by MALDI-TOF MS.
Anti-Infective Agents
/ pharmacology
Bacterial Typing Techniques
Disease Susceptibility
Gram-Positive Bacterial Infections
/ diagnosis
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Molecular Typing
Peptostreptococcus
/ classification
RNA, Ribosomal, 16S
/ genetics
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Treatment Outcome
Urinary Tract Infections
/ diagnosis
Anaerobic urinary tract infection
Antimicrobial susceptibility
Identification
MALDI-TOF MS directly used in urine samples
Peptostreptococcus anaerobius
Journal
Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
15
06
2021
revised:
20
09
2021
accepted:
24
09
2021
pubmed:
10
10
2021
medline:
11
3
2022
entrez:
9
10
2021
Statut:
ppublish
Résumé
Peptostreptococcus anaerobius is a gram-positive anaerobic coccus (GPAC) found in the gastrointestinal and vaginal microbiota. The organism is mainly found in polymicrobial and scarcely in monobacterial infections such as prosthetic and native endocarditis. Anaerobic bacteria have rarely been reported as the cause of urinary tract infection (UTI). Although GPAC are susceptible to most antimicrobials used against anaerobic infections, P. anaerobius has shown to be more resistant. Herein, we report a case of UTI caused by P. anaerobius from a 62-year-old man with a history of urological disease. Surprisingly, the microorganism was directly identified by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) from the urine sample. The isolate was successfully identified by phenotypic methods, MALDI-TOF MS, and 16S rRNA gene sequencing. P. anaerobius showed no β-lactamase-producing activity, was resistant to penicillin, ampicillin, ciprofloxacin and levofloxacin, and displayed intermediate susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid. Successful treatment was achieved with oral amoxicillin-clavulanic acid. Antimicrobial susceptibility testing (AST) should be performed on P. anaerobius isolates due to their unpredictable AST patterns and because empirically administered antimicrobial agents may not be active. This report shows that MALDI-TOF MS, directly used in urine specimens, may be a quick option to diagnose UTI caused by P. anaerobius or other anaerobic bacteria. This review is a compilation of monobacterial infections caused by P. anaerobius published in the literature, their pathogenicity, identification, and data about the antimicrobial susceptibility of P. anaerobius.
Identifiants
pubmed: 34626800
pii: S1075-9964(21)00144-X
doi: 10.1016/j.anaerobe.2021.102461
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
RNA, Ribosomal, 16S
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102461Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interests The authors declare no conflicts of interest.